ISRAEL DAYBOOK: Teva Profit Rises on Cephalon Purchase

(Corrects name of company in first paragraph.)

Teva Pharmaceutical Industries Ltd. (TEVA) said fourth-quarter profit rose 23 percent, boosted by last year’s acquisition of U.S. drugmaker Cephalon Inc.

Earnings excluding some costs climbed to $1.4 billion, or $1.59 a share, from $1.1 billion, or $1.25, a year earlier, the Petach Tikva, Israel-based company said in a statement today. Profit matched the average estimate of $1.59 a share from 25 analysts surveyed by Bloomberg.

     WHAT TO WATCH:
* The Central Bureau of Statistics will release consumer price
index data for January at 6:30 p.m. in Jerusalem.
* The Institute for National Security Studies is scheduled to
hold a panel on: “Israel and the US: National Security
Challenges and their Influence on Bilateral Relations” at 4
p.m. in Jerusalem.

     EQUITY MOVERS:
* Nice Systems Ltd. (NICE IT), the maker of digital surveillance
and monitoring systems will probably report adjusted net income
of $133 million for 2011, according to the median estimate of
six analysts surveyed by Bloomberg.
* Nova Measuring Instruments Ltd. (NVMI IT), a maker of
monitoring systems for the semiconductor manufacturing industry,
is scheduled to release fourth-quarter results.
* Delek Real Estate Ltd. (DLKR IT) Series Heh bondholders of the
property company owned by Isaac Tshuva didn’t approve a request
for a delay in interest payments.

     MARKETS:
* The TA-25 Index fell 0.6 percent to 1,112.64.
* The yield on the Mimshal Shiklit government bond due January
2022 was at 4.6 percent.
* The shekel gained 0.3 percent to 3.7290 a dollar at 8:22 a.m.
in Tel Aviv.
* Corn for March delivery rose 0.2 percent to $6.3475 a bushel.
* Crude oil for March delivery increased 0.9 percent to $101.60
a barrel.
* Gold for immediate delivery advanced 0.4 percent to $1,726.38
an ounce.

To contact the reporters on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net; Sharon Wrobel in Tel Aviv at swrobel4@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net